Mapping the Australian landscape for global health research
This is an in-depth analysis of Australia’s public sector funding for global health research from 2017 to 2023. As a high-income country, Australia has the potential to play a...
Hubs
The Investment Landscape Hub
Powered by G-FINDER, this hub is your go-to resource for data and analysis on the funding landscape for global health R&D. This is where you'll find all the G-FINDER reports across neglected disease, emerging infectious diseases and sexual & reproductive health.
Hub Editors
Dr Paul Barnsley
Research and Analysis Lead
Dr Sabastine Wakdok
Director of Research
Mapping the landscape
What is impacting global health?
Every year the G-FINDER project delivers the latest comprehensive data on global investment into R&D of new products to prevent, diagnose, control or cure diseases which kill millions. We analyse the funding landscape to show you where the money is coming from and where it's going. We reveal areas of growth, areas of decline and where we have gaps. We track which products have entered or moved along the pipeline thanks to this investment. This hub collates this huge resource of data and analysis in one place, where you can explore the findings and assess the implications.
The 2024 G-FINDER Neglected Disease R&D report63%
of global funding came from governments in 2023
Which is a record low
83%
of global philanthropic investment in 2023
Is from the Gates Foundation
12%
of the global vaccine funding in 2023 is for TB
Up from 5% in 2018
Spotlight on latest reports
Relied on by governments, NGOs, private and philanthropic funders, product developers and global health advocates worldwide to inform decisions on R&D funding.
Read more
Is this the new era? Funding for sexual & reproductive health R&D 2018-2023
This is the fourth in a series of reports summarising the state of global funding for LMIC-applicable biomedical research and development targeting a range of sexual &...
%20(1)-808x422.webp)
Smart Decisions: The G-FINDER 2024 Neglected Disease R&D report
Tough choices in global health need people who will make smart decisions. This report provides strong data and solid insights to empower the community.
Watch the launch of Is this the new era?
Online webinar held 17 June 2025
Watch the recording of the report launch event where we reflect on the critical trends, gaps, and opportunities to shape the future of SRH and women's health innovation. Our guest speaker was Dr Nigina Muntean, Chief of the Innovation and Transformation Branch at UNFPA.
All resources in this hub
15 min read
Funding for global health R&D in 2024
An overview of key takeaways from the G-FINDER survey
10 min read
R&D funding for neglected diseases remained stable at $4.3bn in 2024
Dr Paul Barnsley summarises the 2024 funding landscape for neglected diseases
20 min read
State of disunion: The impact of US funding cuts on global health R&D
This report offers a quantified assessment of the actual and potential impact of the 2025 US funding cuts giving a system-wide, data-driven picture of the ripple effects by disease, product, research stage, and sector.
20 min read
Mapping the Australian landscape for global health research
This is an in-depth analysis of Australia’s public sector funding for global health research from 2017 to 2023. As a high-income country, Australia has the potential to play a significant role in addressing global health challenges, especially within the Indo-Pacific region. The report highlights both the strengths and gaps in Australia’s global health research funding.
45 min read
A New Era? Funding for sexual & reproductive health R&D 2018-2023
This is the fourth in a series of reports summarising the state of global funding for LMIC-applicable biomedical research and development targeting a range of sexual & reproductive health and women’s health issues
-404x303.webp)
10 min read
In turbulent times, Europe must double down on its investments in Global Health R&D
Vanessa Candeais shows how investment in global public goods, global solidarity, and equity is a strategic necessity for Europe, providing clarity and leadership for the world and for its own future.
%20(1)-404x211.webp)
10 min read
Smart Decisions launch event notes
We share the summary notes and slides from the launch of the Smart Decisions: the G-FINDER 2024 Neglected Disease R&D report
5 min read
Neglected disease funders
Who was funding what in 2023 and what does this mean for the future?
5 min read
Discussion
Key messages from the 2023 global health R&D funding landscape and our recommendations for funders.
...